Coronavirus Variant A.30 Can Beat Pfizer and AstraZeneca Vaccines; Attacks Kidney, Liver
The A.30 variant showed improved ability to enter most host cells, including kidney, liver, and lung cells. The mutation "enters certain cell lines with increased efficiency and evades antibody-mediated neutralization."
Source: ibtimes.sg